Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
6 studies found for:    12719068 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Botulinum Toxin A for the Treatment of Keratoconus
Condition: Keratoconus
Interventions: Procedure: Subcutaneous injection of botulinum toxin type A;   Drug: Botulinum Toxin Type A
2 Recruiting Collagen Crosslinking for Keratoconus - a Randomized Controlled Clinical Trial
Condition: Keratoconus
Intervention: Device: Corneal Collagen Crosslinking
3 Recruiting Non-inferiority Trial of Iontophoretic Corneal Collagen Crosslinking (CXL) Compared to Standard Corneal Collagen Crosslinking in Progressive Keratoconus.
Condition: Progressive Keratoconus
Interventions: Device: Iontophoretic CXL;   Device: Standard CXL
4 Unknown  Corneal Collagen Crosslinking With Riboflavin for Keratoconus Treatment: A Brazilian Study
Condition: Keratoconus
Intervention: Procedure: Corneal Collagen Crosslinking
5 Unknown  Riboflavin-UVA Induced Collagen Crosslinking Treatment for Corneal Ectasia
Condition: Corneal Ectasia
Interventions: Procedure: riboflavin-induced collagen cross-linking treatment;   Device: Riboflavin-UVA induced collagen cross-linking treatment for corneal ectasia
6 Unknown  Treatment of Keratoconus Using Collagen Cross-Linking
Condition: Keratoconus
Interventions: Drug: Riboflavin-5-phosphate;   Drug: Sham cross-linking

Indicates status has not been verified in more than two years